115180 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Qurient Co., Ltd. engages in the development of novel therapeutics. Its research and development pipeline includes multiple drug resistance tuberculosis, atopic dermatitis, asthma, and cancer. The company was founded by Ki-Yean Nam on July 2, 2008 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
115180 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company